Processa Pharmaceuticals Files Base Prospectus For Up To $50M In Securities; Covers Up To $2.4M Of Common Stock To Be Issued And Sold Under Sales Agreement With A.G.P./Alliance Global Partners
Processa Pharmaceuticals Files Base Prospectus For Up To $50M In Securities; Covers Up To $2.4M Of Common Stock To Be Issued And Sold Under Sales Agreement With A.G.P./Alliance Global Partners
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.